Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does meta-chlorophenylpiperazine (mCPP) activate human platelets?

A E Frampton1, J C H Andrews, A Parfitt

  • 1Academic Department of Accident and Emergency Medicine, Imperial College, St. Mary's Hospital, London, W2 1NY, UK.

Platelets
|November 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of methods to classify ipsilateral breast tumour recurrences as local recurrence or new primary tumour.

NPJ breast cancer·2026
Same author

Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.

Seminars in cancer biology·2017
Same author

Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis.

Cell death & disease·2015
Same author

A Study of Clinical Coding Accuracy in Surgery: Implications for the Use of Administrative Big Data for Outcomes Management.

Annals of surgery·2014
Same author

Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Same author

The efficacy of tacrolimus and sirolimus in heavily pre-treated unresectable thymic malignancies.

Lung cancer (Amsterdam, Netherlands)·2013
Same journal

Hexokinase controls platelet activation and hemostasis.

Platelets·2026
Same journal

Chemiluminescence resonance energy transfer-based method to investigate the platelet surface molecule in acute myocardial infarction.

Platelets·2026
Same journal

Nanobodies to GPVI as alternative reagents for platelet spreading.

Platelets·2026
Same journal

Neural network reveals platelet age from fluorescence microscopy images.

Platelets·2026
Same journal

Sixty years of research into ancestry differences in platelet function.

Platelets·2026
Same journal

Platelet-rich plasma concentrations regulate MSCs osteogenesis via MAPK/PI3K-AKT pathways to mitigate inflammatory bone loss.

Platelets·2026
See all related articles

Meta-chlorophenylpiperazine (mCPP), a serotonin receptor agonist, activates human platelets. This study found mCPP increased median platelet volume in vitro and enhanced platelet activation in vivo, indicating its prothrombotic potential.

Area of Science:

  • Pharmacology
  • Hematology
  • Biochemistry

Background:

  • Meta-chlorophenylpiperazine (mCPP) is a serotonin (5-hydroxytryptamine, 5-HT) receptor agonist used to probe serotonergic function.
  • Platelet activation plays a crucial role in hemostasis and thrombosis.
  • Understanding agents that modulate platelet activity is vital for cardiovascular research.

Purpose of the Study:

  • To investigate the effects of mCPP on human platelet activation.
  • To assess whether mCPP influences platelet volume and aggregation dynamics.
  • To determine if mCPP's effects are mediated through 5-HT receptors.

Main Methods:

  • In vitro: Measured median platelet volume (MPV) using a channelyzer, assessing mCPP's effect alone and in combination with adenosine diphosphate (ADP).

Related Experiment Videos

  • In vivo: Monitored Sonoclot (SCT) parameters (time to inflection - TI, time to peak - TP) after oral administration of mCPP or aspirin.
  • Measured plasma and intraplatelet serotonin levels in both studies.

    • Main Results:

    • In vitro, mCPP significantly increased MPV and enhanced ADP-induced platelet activation.
    • In vivo, mCPP administration significantly shortened TI and TP, indicating enhanced platelet activation.
    • Aspirin did not affect SCT parameters, and no significant changes in serotonin levels were observed.

    Conclusions:

    • Meta-chlorophenylpiperazine (mCPP) directly activates human platelets.
    • mCPP enhances platelet responsiveness, suggesting a potential prothrombotic effect.
    • Platelet activation by mCPP is likely mediated via 5-HT receptors.